Self-reactive CD4+ IL-3+ T cells amplify autoimmune inflammation in myocarditis by inciting monocyte chemotaxis

Author:

Anzai Atsushi12,Mindur John E.1ORCID,Halle Lennard1,Sano Soichi3,Choi Jennifer L.1ORCID,He Shun1,McAlpine Cameron S.1,Chan Christopher T.1,Kahles Florian1,Valet Colin1,Fenn Ashley M.1,Nairz Manfred1,Rattik Sara1,Iwamoto Yoshiko1,Fairweather DeLisa4ORCID,Walsh Kenneth3,Libby Peter5ORCID,Nahrendorf Matthias16ORCID,Swirski Filip K.16ORCID

Affiliation:

1. Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA

2. Department of Cardiology, Keio University School of Medicine, Tokyo, Japan

3. Hematovascular Biology Center, Robert M. Berne Cardiovascular Research Center, University of Virginia School of Medicine, Charlottesville, VA

4. Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL

5. Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Boston, MA

6. Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA

Abstract

Acquisition of self-reactive effector CD4+ T cells is a major component of the autoimmune response that can occur during myocarditis, an inflammatory form of cardiomyopathy. Although the processes by which self-reactive T cells gain effector function have received considerable attention, how these T cells contribute to effector organ inflammation and damage is less clear. Here, we identified an IL-3–dependent amplification loop that exacerbates autoimmune inflammation. In experimental myocarditis, we show that effector organ–accumulating autoreactive IL-3+ CD4+ T cells stimulate IL-3R+ tissue macrophages to produce monocyte-attracting chemokines. The newly recruited monocytes differentiate into antigen-presenting cells that stimulate local IL-3+ CD4+ T cell proliferation, thereby amplifying organ inflammation. Consequently, Il3−/− mice resist developing robust autoimmune inflammation and myocardial dysfunction, whereas therapeutic IL-3 targeting ameliorates disease. This study defines a mechanism that orchestrates inflammation in myocarditis, describes a previously unknown function for IL-3, and identifies IL-3 as a potential therapeutic target in patients with myocarditis.

Funder

National Institutes of Health

American Heart Association

Patricia and Scott Eston MGH Research Scholar

Uehara Memorial Foundation

Kanae Foundation for the Promotion of Medical Science

Japan Society for the Promotion of Science

Boehringer-Ingelheim

Canadian Institutes of Health Research

Banting Research Foundation

Fondation pour la Recherche Medicale

Publisher

Rockefeller University Press

Subject

Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3